Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

6 treatments under study, led by Highfatigue

Research Leaders

6 sponsors active, led by University Hospital, Strasbourg, France

Related Conditions

Often studied with 5 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 4 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

2Total
Not Applicable (1)
Phase 2 (1)

Trial Status

Completed3
Unknown1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 3 completed trials

Clinical Trials (4)

Research Network

Common Treatments

  • Highfatigue1
  • Neuromuscular Fatigue1
  • Olive Leaf Extract1
  • Physical Exercices1
  • Control Protocol No Training1

Active Sponsors

  • University Hospital, Strasbourg, France1
  • Société des Produits Nestlé (SPN)1
  • University of Lausanne1
  • Istanbul Gelisim University1
  • Laboratoire des Adaptations Métaboliques à l'Exercice en conditions Physiologiques et Pathologiques1

Top Investigators

Related Conditions

  • Exercise1
  • Healthy Volunteers1
  • Loadvelocity Variables1
  • Skeletal Muscle Adaptations1
  • Exercise Intensity1

Activity Timeline